Related Experiment Video
Updated: Aug 14, 2026
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy
Wayne L Miller1, Brooks S Edwards, Walter K Kremers
1Mayo Medical Center, Rochester, Minnesota, USA.
Insights
Elevated donor troponin levels do not predict cardiac allograft vasculopathy (CAV). Instead, higher donor troponin levels are linked to a reduced risk of developing CAV, suggesting a protective effect.
Area of Science:
- Cardiology
- Transplantation Immunology
- Biomarker Research
Background:
- Cardiac allograft vasculopathy (CAV) is a primary cause of death and illness in heart transplant recipients.
- CAV is thought to result from immune-mediated endothelial injury after heart transplantation.
- Donor serum troponin levels are investigated as potential biomarkers for CAV.
Purpose of the Study:
- To investigate the association between donor troponin levels and the development of cardiac allograft vasculopathy (CAV).
Main Methods:
- Retrospective analysis of troponin levels in cardiac donor patients.
- Monitoring of heart transplant recipients (N = 171) for CAV development via angiography.
Main Results:
- Significant CAV was observed in 6% of transplant recipients.
- Troponin levels showed an inverse relationship with CAV severity.
Conclusions:
- Elevated donor troponin levels are not associated with increased CAV development.
- Higher donor troponin levels correlate with a reduced long-term risk of CAV.
- Donor-released proteins may have a protective effect against CAV.
Background:
Cardiac allograft vasculopathy (CAV) is considered a major cause of morbidity and mortality in transplant recipients and may reflect immune-mediated endothelial injury in response to the donor heart. Elevated troponin levels in the donor serum might provide a marker for this phenomenon; therefore, we evaluated the relationship of donor troponin levels to the development of CAV.
Methods:
A retrospective analysis of troponin levels was undertaken from cardiac donor patients, and transplant recipients were monitored for the development of vasculopathy by angiography (N = 171).
Results:
Angiographically significant CAV developed in 6% of transplantation patients and troponin levels were inversely related to the severity of CAV.
Conclusions:
Elevated donor troponin levels are not associated with the development of CAV but rather with a significantly reduced long-term risk of developing CAV, suggesting a possible protective effect of donor released protein.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:28Kidney Transplant I: Introduction